Rhoda E. Kuc

4.8k citations

98 papers · 3.4k indexed · h-index 30

Impact in

Cardiology and Cardiovascular Medicine top 2%
- Renin-Angiotensin System Studies
Pharmacology top 1%
- Apelin-related biomedical research

Papers in

Physiology 46
- Nitric Oxide and Endothelin Effects 45
Pharmacology 29
- Apelin-related biomedical research 29

Co-authors: Anthony P. Davenport Janet J. Maguire Gillian O’Reilly Peter Molenaar Christopher Plumpton Peiran Yang Andrew Sharkey Cai Read
Journals: Journal of Cardiovascular Pharmacology (19 papers)British Journal of Pharmacology (12 papers)Life Sciences (7 papers)Clinical Science (5 papers)Peptides (5 papers)
Partner nations: United Kingdom United States Sweden

In The Last Decade

Rhoda E. Kuc

98 papers receiving 3.3k citations

Peers

Countries citing papers authored by Rhoda E. Kuc

Since Specialization

Citations

This map shows the geographic impact of Rhoda E. Kuc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhoda E. Kuc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhoda E. Kuc more than expected).

Fields of papers citing papers by Rhoda E. Kuc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhoda E. Kuc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhoda E. Kuc. The network helps show where Rhoda E. Kuc may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rhoda E. Kuc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rhoda E. Kuc Line = papers co-authored together Rhoda E. Kuc links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma Frontiers in Neuroscience ·Thomas Williams, Karim Diallo, Rhoda E. Kuc, Kieran Smith, Anna Paterson, Kieren Allinson, Janet J. Maguire, Anthony P. Davenport	2024	4
2	Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function British Journal of Clinical Pharmacology ·Duuamene Nyimanu, Fiona A. Chapman, Peter J. Gallacher, Rhoda E. Kuc, Thomas Williams, David E. Newby, Janet J. Maguire, Anthony P. Davenport, Neeraj Dhaun	2022	14
3	Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytes Cardiovascular Research ·Robyn Macrae, Maria Colzani, Thomas Williams, N. Mityakina, Rhoda E. Kuc, William James Mieras, William G. Bernard, Emma Robinson, Emma E. Davenport, Janet J. Maguire, Sanjay Sinha, Anthony P. Davenport	2022	8
4	Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection Communications Biology ·Thomas Williams, Maria Colzani, Robyn Macrae, Emma Robinson, Stuart Bloor, Edward JD Greenwood, Jerzy. Kitowski, Yetunde, Rhoda E. Kuc, Duuamene Nyimanu, Janet J. Maguire, Paul J. Lehner, Sanjay Sinha, Anthony P. Davenport	2021	11
5	Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites Scientific Reports ·Thomas Williams, Yetunde, Robyn Macrae, Rhoda E. Kuc, Duuamene Nyimanu, Anna Paterson, Sanjay Sinha, Janet J. Maguire, Anthony P. Davenport	2021	17
6	The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo Frontiers in Pharmacology ·Cai Read, Duuamene Nyimanu, Peiran Yang, Rhoda E. Kuc, Thomas Williams, J. Vigo, Richard Foster, Robert C. Glen, Janet J. Maguire, Anthony P. Davenport	2021	18
7	Endothelin ET A receptors predominate in chronic thromboembolic pulmonary hypertension Life Sciences ·Mark Southwood, Robert V. MacKenzie Ross, Rhoda E. Kuc, Guy Hagan, Karen Sheares, David P. Jenkins, Martin Goddard, Anthony P. Davenport, Joanna Pepke‐Żaba	2016	16
8	Abstract 13911: ELABELA/Toddler (Apela), is an Endogenous Ligand of the Human Apelin Receptor and is Reduced in Pulmonary Arterial Hypertension Circulation ·Peiran Yang, Janet J. Maguire, Rhoda E. Kuc, Mark Southwood, Nicholas W. Morrell, Anthony P. Davenport	2015	1
9	Abstract 15352: ELABELA/Toddler, a Critical Regulator of Cardiac Development, is Expressed in the Human Cardiovascular System and Binds the Apelin Receptor Circulation ·Peiran Yang, Janet J. Maguire, Rhoda E. Kuc, Keith Siew, Lalarukh Haris Shaikh, Rubben Torella, Robert C. Glen, Anthony P. Davenport	2014	2
10	Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension Life Sciences ·Rhoda E. Kuc, Jens Arnert, Janet J. Maguire, Peiran Yang, Lü Long, Mark Toshner, Nicholas W. Morrell, Anthony P. Davenport	2014	14
11	Cellular Localization of Receptors Using Antibodies Visualized by Light and Dual Labeling Confocal Microscopy Methods in molecular biology ·Anthony P. Davenport, Rhoda E. Kuc	2012	1
12	Inotropic Action of the Puberty Hormone Kisspeptin in Rat, Mouse and Human: Cardiovascular Distribution and Characteristics of the Kisspeptin Receptor PLoS ONE ·Janet J. Maguire, Ajeng Adnya Sari, Emma J. Mead, Rhoda E. Kuc, Xavier d’Anglemont de Tassigny, William H Colledge, Anthony P. Davenport	2011	24
13	Kisspeptins Are Novel Potent Vasoconstrictors in Humans, with a Discrete Localization of Their Receptor, G Protein-Coupled Receptor 54, to Atherosclerosis-Prone Vessels Endocrinology ·Emma J. Mead, Janet J. Maguire, Rhoda E. Kuc, Anthony P. Davenport	2006	113
14	Comparison of Endothelin-A and Endothelin-B Receptor Distribution Visualized by Radioligand Binding versus Immunocytochemical Localization using Subtype Selective Antisera Journal of Cardiovascular Pharmacology ·Rhoda E. Kuc, Anthony P. Davenport	2004	44
15	Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries Peptides ·Janet J. Maguire, Rhoda E. Kuc, Katherine Wiley, Matthias J. Kleinz, Anthony P. Davenport	2004	93
16	First demonstration in humans of systemic neutral endopeptidase and endothelin converting enzyme inhibition using a new orally active dual metalloprotease inhibitor SLV 306 Journal of the American College of Cardiology ·Alison Seed, Rhoda E. Kuc, Anthony P. Davenport, Michael Ashby, Chris Hillier, Shaonan Qiu, Hans Essers, John J.V. McMurray	2003	1
17	Vasoconstrictor activity of novel endothelin peptide, ET‐1_{(1 – 31)}, in human mammary and coronary arteries in vitro British Journal of Pharmacology ·Janet J. Maguire, Rhoda E. Kuc, Anthony P. Davenport	2001	32
18	Endothelin-A-Receptors in Human Aorta and Pulmonary Arteries are Downregulated in Patients With Cardiovascular Disease Journal of Cardiovascular Pharmacology ·Rhoda E. Kuc, Anthony P. Davenport	2000	28
19	Potency of PD155080, an Orally Active ETA Receptor Antagonist, Determined for Human Endothelin Receptors Journal of Cardiovascular Pharmacology ·Janet J. Maguire, Rhoda E. Kuc, Annette M. Doherty, Anthony P. Davenport	1995	5
20	Characterization of two new ET_B selective radioligands, [¹²⁵I]‐BQ3020 and [¹²⁵I]‐[Ala^1,3,11,15]ET‐1 in human heart British Journal of Pharmacology ·Peter Molenaar, Rhoda E. Kuc, Anthony P. Davenport	1992	56

About Rhoda E. Kuc

Rhoda E. Kuc is a scholar working on Physiology, Pharmacology, Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 98 papers that have together received 3.4k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (45 papers), Receptor Mechanisms and Signaling (30 papers), Apelin-related biomedical research (29 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (26 papers), Renin-Angiotensin System Studies (15 papers), Nuclear Receptors and Signaling (14 papers), Hormonal Regulation and Hypertension (8 papers) and Neuropeptides and Animal Physiology (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.2k citations), Pharmacology (872 citations), Physiology (1.2k citations), Endocrinology, Diabetes and Metabolism (559 citations) and Cellular and Molecular Neuroscience (507 citations). Rhoda E. Kuc has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Anthony P. Davenport, Janet J. Maguire, Gillian O’Reilly, Peter Molenaar, Christopher Plumpton, Peiran Yang, Andrew Sharkey, Cai Read, Robert C. Glen and Katherine Wiley. Their work appears in journals such as Journal of Cardiovascular Pharmacology, British Journal of Pharmacology, Life Sciences, Clinical Science and Peptides.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact